Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09BBA
|
|||
| Drug Name |
TAK-071
|
|||
| Synonyms |
WFSARWQASFQZMG-FGZHOGPDSA-N; 1820812-16-5
Click to Show/Hide
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 1 | [1], [2] | |
| Company |
Takeda Pharmaceuticals Deerfield, IL
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H24FN3O3
|
|||
| Canonical SMILES |
CC1=C(C2=C(C=C1CC3=CC=C(C=C3)N4C=CC=N4)C(=O)N(C2)C5COCCC5O)F
|
|||
| InChI |
1S/C24H24FN3O3/c1-15-17(11-16-3-5-18(6-4-16)28-9-2-8-26-28)12-19-20(23(15)25)13-27(24(19)30)21-14-31-10-7-22(21)29/h2-6,8-9,12,21-22,29H,7,10-11,13-14H2,1H3/t21-,22-/m0/s1
|
|||
| InChIKey |
WFSARWQASFQZMG-VXKWHMMOSA-N
|
|||
| CAS Number |
CAS 1820812-16-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.